Screening and identification of circulating miRNA molecular markers in T2DM based on molecular network

Guariguata, 2014, Global estimates of diabetes prevalence for 2013 and projections for 2035, Diabetes Res Clin Pract, 103, 137, 10.1016/j.diabres.2013.11.002 Jacobs, 2017, Burden of mortality attributable to diagnosed diabetes: a nationwide analysis based on claims data from 65 million people in Germany, Diabetes Care, 40, 1703, 10.2337/dc17-0954 Xu, 2013, Prevalence and control of diabetes in Chinese adults, Jama, 310, 948, 10.1001/jama.2013.168118 Higgins, 2013, HbA1c for screening and diagnosis of diabetes mellitus, Endocrine, 43, 266, 10.1007/s12020-012-9768-y Ding, 2016, Identification of the differential expression of serum microRNA in type 2 diabetes, Biosci Biotechnol Biochem, 80, 461, 10.1080/09168451.2015.1107460 Mayr, 2013, MicroRNAs within the continuum of postgenomics biomarker discovery, Arterioscler Thromb Vasc Biol, 33, 206, 10.1161/ATVBAHA.112.300141 Ghai, 2019, Extracellular vesicle encapsulated microRNAs in patients with type 2 diabetes are affected by metformin treatment, J Clin Med, 8, 10.3390/jcm8050617 Arredondo, 2018, Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America, Glob Public Health, 13, 780, 10.1080/17441692.2017.1316414 He, 2017, A systematic study of dysregulated microRNA in type 2 diabetes mellitus, Int J Mol Sci, 18, 10.3390/ijms18030456 Hu, 2015, Down-regulation of the miR-543 alleviates insulin resistance through targeting the SIRT1, Biochem Biophys Res Commun, 468, 781, 10.1016/j.bbrc.2015.11.032